ArticleAnnals of medicine2025
Higher cardiometabolic index elevates the risk of hyperuricemia in the elderly: findings from the China health and retirement longitudinal study.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperuricemia (HUA) is the direct cause of gouty arthritis. The association between cardiometabolic index (CMI) and hyperuricemia remains unclear. This study aimed to examine this association in the middle-aged and elderly Chinese for preventing gouty arthritis at early stage.
methodThis study was based on China Health and Retirement Longitudinal Study (CHARLS, survey 2011 and 2015). Four logistic regression models were established. Sensitive analysis including propensity score matching (PSM) and inverse probability of treatment weighting (IPTW), etc. were applied to identify the robustness of the models. Restricted cubic spline (RCS) was adopted to further explore the non-linear relationship between the CMI and hyperuricemia. Moreover, as the HUA was caused by the abnormal elevation of serum uric acid (SUA), Cross-lagged panel model (CLPM) was used to investigate the causal relationship between CMI and SUA. Mediation analysis was used to explore the possible mechanisms about the interference of CMI to HUA.
resultsA total of 5,653 participants were enrolled in this study. A positive association between CMI and hyperuricemia was found in both the cross-sectional and longitudinal analysis. In the four logistic regression models of longitudinal analysis, the ORs were 2.09(1.73,2.54), 2.20(1.81,2.68), 2.09(1.71,2.56) and 1.93(1.57,2.36), respectively. Results maintained consistent in the sensitive analysis including PSM and IPTW. Importantly, it still holds in the participants with normal body mass index. Additionally, a non-linear relationship was revealed
conclusionElevated CMI is an independent risk factor for hyperuricemia, and associated with the increasing SUA levels in a temporal sequence manner, effects potentially mediated in part by inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.